+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

India Kidney Function Test Market, Competition, Forecast & Opportunities, 2029

  • PDF Icon

    Report

  • 73 Pages
  • October 2023
  • Region: India
  • TechSci Research
  • ID: 5893613
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The India kidney function test market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the increased awareness about kidney diseases, that how it is important to detect kidney diseases early and to raise awareness among the people regarding kidney diseases in India. There has been a significant increase in the prevalence of kidney diseases in India over the last few decades. This increase is mainly attributed to changes in lifestyle, including unhealthy diets, lack of physical activity, and an increase in the prevalence of diabetes and hypertension. Patients are more informed about the benefits of early detection of kidney diseases, as a result, there is a growing need for early detection and management of kidney disease, which has led to an increase in demand for kidney function tests. These advancements have improved the accuracy and reliability of the tests, leading to greater acceptance of the tests by patients and healthcare professionals. Indian government has taken so many initiatives to improve healthcare in the country, including measures to increase access to kidney function tests. For instance, the National Health Mission in India provides free diagnostic tests, including kidney function tests, to eligible individuals, which has helped to increase access to these tests. As the growing Indian economy has led to greater investments in healthcare infrastructure, including diagnostic labs and testing facilities, it has helped to fuel the growth of the India kidney function test market.

Increasing Prevalence of Chronic Kidney Disease Helps in Rising the India Kidney Function Test Market Share

Chronic kidney disease (CKD) is a major public health concern in India, and the prevalence of the disease has been increasing in recent years. Around 10% of the Indian population suffers from chronic kidney disease, and every year over 1 lakh cases of renal failure. There are several factors that have contributed to the rising incidence of CKD in India, including Diabetes which is one of the leading causes of chronic kidney disease in India. According to the International Diabetes Federation, India has the second-largest population of people with diabetes in the world, with an estimated 77 million people affected. Hypertension or high blood pressure is another major contributor to the development of chronic kidney disease in India. Hypertension is common in India, with an estimated 25-30% of the adult population affected. Unhealthy lifestyle choices, such as a diet high in salt and fat, lack of physical activity, and tobacco use, are also contributing to the increasing prevalence of chronic kidney disease in India. India has a high proportion of aged population, and older adults are more likely to develop chronic kidney disease than younger individuals. Environmental factors such as exposure to environmental toxins and pollution can also contribute to the development of chronic kidney disease. The increasing prevalence of chronic kidney disease in India has significant implications for public health, as the disease can lead to serious complications such as kidney failure, cardiovascular disease, and premature death. Early detection and management of this disease are critical in reducing the burden of the disease in India, and kidney function tests play an important role in achieving this goal. These factors are anticipated to grow the India kidney function test market.

Growing Awareness regarding Kidney Diseases Help in Expanding India Kidney Function Test Market

There has been a growing awareness about kidney disease in India in recent years. Several factors have contributed to this awareness, including Increasing prevalence of kidney disease in India has led to increased attention and awareness about the disease among the public. The Indian government has launched several initiatives aimed at raising awareness about kidney disease, such as the National Program for Prevention and the National Health Mission. The Indian media has played a significant role in raising awareness about kidney disease through articles, television shows, and other forms of media. Patient advocacy groups, several patient advocacy groups in India are working to raise awareness about kidney disease and the importance of early detection and management. Healthcare professionals, including doctors and nurses, are also playing a critical role in raising awareness about kidney disease and encouraging patients to undergo kidney function tests for early detection of kidney disease.

The growing awareness about kidney disease in India is helping to improve early detection and management of the disease. This is important in reducing the burden of kidney disease in India, which has significant implications for public health and the economy. These factors are anticipated to grow the India kidney function test market.

Technological Advancements Helps India’s Kidney Function Test Market to Grow

Recently, there have been significant technological advancements in kidney function tests in India. Some of these advancements include automated tests, which has greatly improved the efficiency and accuracy of kidney function tests in India. Automated tests are more reliable and can be performed quickly, allowing for faster diagnosis and treatment. Point-of-care testing is a type of diagnostic testing that can be performed at the bedside, without the need for laboratory facilities. This technology has improved access to kidney function tests in remote and underserved areas of India. Biomarkers are substances in the blood or urine that can indicate the presence of kidney disease. The use of biomarkers in kidney function tests has improved the accuracy of diagnosis and monitoring of kidney disease in India. Imaging technologies, such as ultrasound, CT scans, and MRI scans can be used to detect structural abnormalities in the kidneys. These technologies are increasingly being used in kidney function tests in India. These factors are anticipated to grow the India kidney function test market.

Rising Demand from Private Healthcare Providers Helps in the Increment of India Kidney Function Test Market

There has been a rising demand from private healthcare providers in the kidney function test market in India. Several factors have contributed to this trend, including Increase in the number of private healthcare providers, Over the last few years, there has been a significant increase in the number of private healthcare providers in India. Private healthcare providers are more likely to use advanced technologies and offer a wider range of services, including kidney function tests. Greater focus on preventive healthcare, the private healthcare providers in India are placing a greater emphasis on preventive healthcare, which includes early detection and management of kidney disease. This has led to an increase in demand for kidney function tests. Improved access to healthcare, private healthcare providers in India are often located in urban areas and offer better access to healthcare facilities, which has contributed to an increase in demand for kidney function tests. Due to the increased affordability with the rise of private healthcare providers, there has been greater competition in the market, which has led to lower prices for kidney function tests. This has made these tests more affordable for patients. Private healthcare providers in India offer a better patient experience, with shorter wait times, more personalized care, and better amenities. This has led to a greater preference for private healthcare providers for kidney function tests.

The rising demand from private healthcare providers in the kidney function test market in India reflects a shift towards more advanced and preventive healthcare services. While private healthcare providers may not be accessible to all patients, they are playing an increasingly important role in improving access to kidney function tests and other healthcare services in India. This factor is anticipated to grow the India kidney function test market.

Market Segmentation

India kidney function test market can be segmented by test type, imaging, component, end user, and region. By test type, India kidney function test market can be segmented into urine tests and blood tests. Urine tests can be further segmented into urine protein tests, creatinine clearance tests, and microalbumin tests. Blood tests can be further categorized into serum creatinine tests, glomerular filtration rate tests, and blood urea nitrogen tests. By imaging, India kidney function test market can be segmented into MRI, CT-Scan, ultrasound, and renal scintigraphy. By component, India kidney function test can be segmented into dipsticks, reagents, kits & assays, and others. By end user, India kidney function test market can be segmented into hospitals & clinics, diagnostic laboratories, academic and research institute, and others. By region, India kidney function test market can be segmented into North India, South India, East India, and West India.

Market Players

Metropolis Healthcare Ltd, Dr Lal Path Labs Ltd, SRL Diagnostics Pvt Ltd, Abbott India Ltd., Roche Diagnostics India Pvt. Ltd., Siemens Healthineers India Ltd., Bio-Rad Laboratories (India) Pvt. Ltd., Beckman Coulter India Pvt. Ltd., Merck India Pvt Ltd, and Trivitron Healthcare Pvt Ltd are the major key players in India kidney function test market.

Report Scope:

In this report, the India kidney function test market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

India Kidney Function Test Market, By Test Type:

  • Urine Test
  • Urine Protein Tests
  • Creatinine Clearance Tests
  • Microalbumin Tests
  • Blood Test
  • Serum Creatinine Tests
  • Glomerular Filtration Rate Tests
  • Blood Urea Nitrogen Tests

India Kidney Function Test Market, By Imaging:

  • MRI
  • CT-Scan
  • Ultrasound
  • Renal Scintigraphy

India Kidney Function Test Market, By Component:

  • Dipsticks
  • Reagents
  • Kits & Essays

India Kidney Function Test Market, By End User:

  • Hospitals and Clinics
  • Diagnostics Laboratories
  • Academic and Research Institute

India Kidney Function Test Market, By Region:

  • North India
  • South India
  • East India
  • West India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present India kidney function test market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. India Kidney Function Test Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Test Type (Urine Test (Urine Protein Test, Creatinine Tests, Clearance Test, Microalbumin Test) Blood Test (Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests)).
5.2.2. By Imaging (MRI, CT-Scan, Ultrasound, Renal Scintigraphy)
5.2.3. By Component (Dipsticks, Reagents, Kits & Essays)
5.2.4. By End User (Hospitals and Clinics, Diagnostics Laboratories, Academic and Research Institutes, others)
5.2.5. By Region (North India, South India, East India, West India)
6. North India Kidney Function Test Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type
6.2.2. By Imaging
6.2.3. By Component
6.2.4. By End User
7. South India Kidney Function Test Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By Imaging
7.2.3. By Component
7.2.4. By End User
8. East India Kidney Function Test Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By Imaging
8.2.3. By Component
8.2.4. By End User
9. West India Kidney Function Test Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Test Type
9.2.2. By Imaging
9.2.3. By Component
9.2.4. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Merger & Acquisition
11.2. Product Development
11.3. Recent Developments
12. Policy & Regulatory Landscape
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. India Economic Profile
15. Competitive Landscape
15.1. Business Overview
15.2. Company Snapshot
15.3. Products & Services
15.4. Financials (As Reported)
15.5. Recent Developments
15.5.1. Abbott India Ltd
15.5.2. Roche Diagnostics India Pvt. Ltd
15.5.3. Siemens Healthineers India
15.5.4. Bio-Rad Laboratories (India) Pvt. Ltd
15.5.5. Beckman Coulter India Pvt. Ltd
15.5.6. Merck India
15.5.7. Trivitron Healthcare.
15.5.8. Dr. Lal Pathlabs Pvt. Ltd.
15.5.9. SRL Diagnostics Pvt. Ltd.
15.5.10. Metropolis Healthcare Ltd.
16. Strategic Recommendations
About the Publisher & Disclaimer

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott India Ltd
  • Roche Diagnostics India Pvt. Ltd
  • Siemens Healthineers India
  • Bio-Rad Laboratories (India) Pvt. Ltd
  • Beckman Coulter India Pvt. Ltd
  • Merck India
  • Trivitron Healthcare.
  • Dr. Lal Pathlabs Pvt. Ltd.
  • SRL Diagnostics Pvt. Ltd.
  • Metropolis Healthcare Ltd.

Table Information